DEVELOPMENT FUNDING BOND PURCHASE AGREEMENTDevelopment Funding Bond Purchase Agreement • March 16th, 2022 • MorphoSys AG • Pharmaceutical preparations • New York
This DEVELOPMENT FUNDING BOND PURCHASE AGREEMENT, dated as of June 2, 2021 (this “Agreement”), is made and entered into by and between MorphoSys AG, a German stock corporation (Aktiengesellschaft) (the “Guarantor”), and Royalty Pharma USA, Inc., a Delaware corporation (the “Buyer”), and, effective as of its execution of a Joinder at or following the closing of the Merger (as defined below), Constellation Pharmaceuticals, Inc., a Delaware corporation (the “Issuer”).
